{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:00:27Z","timestamp":1772776827686,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Portuguese Foundation for Science and Technology (FCT)"},{"name":"Portugal-Spain capacitation program in Nanoscience and Nanotechnology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.ijpharm.2012.05.018","type":"journal-article","created":{"date-parts":[[2012,5,22]],"date-time":"2012-05-22T01:22:47Z","timestamp":1337649767000},"page":"9-19","source":"Crossref","is-referenced-by-count":43,"title":["Toward a siRNA-containing nanoparticle targeted to breast cancer cells and the tumor microenvironment"],"prefix":"10.1016","volume":"434","author":[{"given":"L\u00edgia C.","family":"Gomes-da-Silva","sequence":"first","affiliation":[]},{"given":"Adriana O.","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds M.","family":"Bimbo","sequence":"additional","affiliation":[]},{"given":"Vera","family":"Moura","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 S.","family":"Ramalho","sequence":"additional","affiliation":[]},{"given":"Maria C.","family":"Pedroso de Lima","sequence":"additional","affiliation":[]},{"given":"S\u00e9rgio","family":"Sim\u00f5es","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o N.","family":"Moreira","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.05.018_bib0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.drup.2009.12.001","article-title":"Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy","volume":"13","author":"Abdollahi","year":"2010","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0010","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0005-2736(91)90201-I","article-title":"Pharmacokinetics of stealth versus conventional liposomes: effect of dose","volume":"1068","author":"Allen","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0005-2736(91)90246-5","article-title":"Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo","volume":"1066","author":"Allen","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0025","doi-asserted-by":"crossref","first-page":"15549","DOI":"10.1073\/pnas.0707461104","article-title":"Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging","volume":"104","author":"Bartlett","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0030","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nchembio839","article-title":"RNAi therapeutics: a potential new class of pharmaceutical drugs","volume":"2","author":"Bumcrot","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0035","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nature07758","article-title":"The promises and pitfalls of RNA-interference-based therapeutics","volume":"457","author":"Castanotto","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0040","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1083\/jcb.200304132","article-title":"Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels","volume":"163","author":"Christian","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0045","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0005-2736(00)00342-4","article-title":"Kinetic analysis of the initial steps involved in lipoplex\u2013cell interactions: effect of various factors that influence transfection activity","volume":"1510","author":"da Cruz","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0050","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1038\/mt.2011.142","article-title":"Selective Therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma","volume":"19","author":"Di Paolo","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0055","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0060","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1101\/gad.862301","article-title":"RNA interference is mediated by 21- and 22-nucleotide RNAs","volume":"15","author":"Elbashir","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0065","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect","volume":"63","author":"Fang","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0070","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0075","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1086\/504267","article-title":"Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference","volume":"193","author":"Geisbert","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0080","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.biochi.2007.06.012","article-title":"Short interfering RNA (siRNA), a novel therapeutic tool acting on angiogenesis","volume":"89","author":"Hadj-Slimane","year":"2007","journal-title":"Biochimie"},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0085","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0090","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1126\/science.1073827","article-title":"A microRNA in a multiple-turnover RNAi enzyme complex","volume":"297","author":"Hutvagner","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-5793(99)01320-4","article-title":"A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs","volume":"460","author":"Ishida","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0100","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.drudis.2006.07.005","article-title":"Exploiting the enhanced permeability and retention effect for tumor targeting","volume":"11","author":"Iyer","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0110","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1172\/JCI37515","article-title":"Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice","volume":"119","author":"Judge","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0115","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.mt.6300168","article-title":"Systemic and specific delivery of small interfering RNAs to the liver mediated by apolipoprotein A\u2013I","volume":"15","author":"Kim","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0120","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/mp800049w","article-title":"Pharmacokinetics and biodistribution of nanoparticles","volume":"5","author":"Li","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0125","doi-asserted-by":"crossref","first-page":"34970","DOI":"10.1074\/jbc.273.52.34970","article-title":"Generation of destabilized green fluorescent protein as a transcription reporter","volume":"273","author":"Li","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1535-6108(04)00025-X","article-title":"Aminopeptidase A is a functional target in angiogenic blood vessels","volume":"5","author":"Marchio","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0135","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/S0006-3495(01)76202-9","article-title":"Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes","volume":"80","author":"Maurer","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1021\/bc9004365","article-title":"Transferrin receptor-targeted liposomes encapsulating anti-BCR-ABL siRNA or asODN for chronic myeloid leukemia treatment","volume":"21","author":"Mendonca","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1078\/0171-9335-00363","article-title":"PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles","volume":"83","author":"Mishra","year":"2004","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0005-2736(01)00411-4","article-title":"Targeting Stealth liposomes in a murine model of human small cell lung cancer","volume":"1515","author":"Moreira","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0005-2736(01)00386-8","article-title":"A growth factor antagonist as a targeting agent for sterically stabilized liposomes in human small cell lung cancer","volume":"1514","author":"Moreira","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0160","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1014434732752","article-title":"Use of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity","volume":"19","author":"Moreira","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0165","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1166\/jnn.2008.319","article-title":"Non-viral lipid-based nanoparticles for targeted cancer systemic gene silencing","volume":"8","author":"Moreira","year":"2008","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0170","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/nbt1122","article-title":"Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs","volume":"23","author":"Morrissey","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0175","article-title":"Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer","author":"Moura","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0180","doi-asserted-by":"crossref","first-page":"11460","DOI":"10.1073\/pnas.88.24.11460","article-title":"Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy","volume":"88","author":"Papahadjopoulos","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0185","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1073\/pnas.062189599","article-title":"A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo","volume":"99","author":"Porkka","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0190","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2006.10.029","article-title":"Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides","volume":"117","author":"Remaut","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0195","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbamem.2009.12.001","article-title":"Design of peptide-targeted liposomes containing nucleic acids","author":"Santos","year":"2010","journal-title":"Biochim. Biophys. Acta 1798"},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0200","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0005-2736(00)00343-6","article-title":"Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures","volume":"1510","author":"Semple","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2736(01)00399-6","article-title":"Characterization of the inhibitory effect of PEG\u2013lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes","volume":"1558","author":"Song","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-642-00477-3_1","article-title":"Passive and active drug targeting: drug delivery to tumors as an example","author":"Torchilin","year":"2010","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0215","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jconrel.2003.11.021","article-title":"Targeted delivery of antisense oligodeoxynucleotides to folate receptor-overexpressing tumor cells","volume":"95","author":"Yang","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0220","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/sj.gt.3300965","article-title":"Stabilized plasmid-lipid particles for regional gene therapy: formulation and transfection properties","volume":"6","author":"Zhang","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.ijpharm.2012.05.018_bib0225","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature04688","article-title":"RNAi-mediated gene silencing in non-human primates","volume":"441","author":"Zimmermann","year":"2006","journal-title":"Nature"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312005029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312005029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T09:56:02Z","timestamp":1542966962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312005029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":45,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0378517312005029"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.05.018","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}